UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

March 22, 2021

Date of Report (Date of earliest event reported)

DBV Technologies S.A.

(Exact name of registrant as specified in its charter)

Registrant’s telephone number, including area code: +33 1 55 42 78 78

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

    Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

On March 22, 2021, Claire Giraut provided the Board of Directors (the “Board”) of DBV Technologies S.A. (the “Company”) with notice of her resignation from the Board, effective March 22, 2021. Ms. Giraut’s resignation was not the result of any dispute or disagreement with the Company or the Board.

On March 23, 2021, the Board appointed Viviane Monges the Chairperson of the Audit Committee of the Board, in replacement of Ms. Giraut.

The Company issued a press release on March 26, 2021, announcing the director resignation and committee composition changes described in Item 5.02 above and the date of the Company’s Annual General Meeting (as defined in Item 8.01). The press release making this announcement is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The information in this Item 7.01, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

On March 26, 2021, the Company announced that its Ordinary and Extraordinary General Meeting of Shareholders (the “Annual General Meeting”) will be convened on May 19, 2021. The Company will provide further details and procedures with respect to the Annual General Meeting at a later date, including in a proxy statement related to the Annual General Meeting that will be filed with the Securities and Exchange Commission.

(d) Exhibits

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.